Sotuvning operatsion marjasi: Compass Therapeutics Inc (CMPX)

Compass Therapeutics Corp (CMPX) kompaniyasining korporativ logotipi

Compass Therapeutics maqsadli antitelalarni ishlab chiqish orqali immuno-onkologiya sohasida kuchli ilmiy salohiyatga ega. Biroq, sog'liqni saqlash gigantlari bilan bo'lgan shiddatli raqobat GURU.Markets platformasida taqdim etilgan operatsion marja grafigini sinchiklab o'rganishni talab qiladi; 0.00 qiymati ushbu metrikaning so'nggi ko'rsatkichini aks ettiradi. Biznes barqarorligi hozirda patent qonunchiligi va davom etayotgan klinik sinovlarning muvaffaqiyatiga bog'liq.

CMPX: compasstherapeutics.com Operatsion foyda normasi 04.07.2022 - 19.11.2026

Compass Therapeutics - tahliliy kesimlar va asosiy koʻrsatkichlar (CMPX)

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:CMPX, Compass Therapeutics, Inc.
Compass Therapeutics Corp asosiy tovari

Compass Therapeutics (CMPX) kompaniyasining fundamental baholanishi operatsion foyda prizmasi orqali xarajatlarni boshqarish samaradorligini tahlil qilishni talab qiladi. Ushbu operatsion foyda marjasi qarz majburiyatlari va soliqlarni hisobga olishdan oldin, asosiy faoliyatdan olingan sof daromad ulushini o'lchaydi. Ushbu ko'rsatkich biznesning tashqi moliyalashtirishsiz pul oqimini yaratish qobiliyatini aks ettiradi. Compass Therapeutics (CMPX) uchun bu antitanachlar ishlab chiqish xarajatlarini nazorat qilishning muhim belgisi hisoblanadi. Ushbu ko'rsatkichdagi ijobiy dinamika dori vositalarining sug'urta qoplash bozoriga kirishdan oldin tijorat nuqtai nazaridan hayotiyligini tasdiqlaydi.

Compass Therapeutics kimlar bilan raqobatlashadi

Sotuvning operatsion marjasi IBRX|IMCR - Operatsion foyda bo'yicha marjinallik|Sotuvning operatsion marjasi JANX (Janux Pharma)|Operatsion foyda koeffitsiyenti RCUS|Operatsion marja ZYME (Zymeworks)|Operatsion foyda normasi TNGX|iovance.com - Operatsion marja|Sotuvning operatsion rentabelligi Immatics Biotechnologies|Xencor, Inc. (XNCR) - Operatsion rentabellik|Replimune Group, Inc. - Operatsion foyda normasi|LYEL (lyell.com) - Operatsion marja|Operatsion marja Innate Pharma SA|Operatsion rentabellik pyxisoncology.com (PYXS)|CGEN: Operatsion foyda marjasi|IO Biotech Inc - Sotuvning operatsion marjasi|sutrobio.com (STRO) - Sotuvning operatsion rentabelligi|INKT - Operatsion rentabellik|werewolftx.com (HOWL) - Sotuvning operatsion marjasi|Immix (IMMX) - Operatsion rentabellik|ALXO (ALX Oncology Holdings) - Operatsion rentabellik|Sotuvning operatsion marjasi CUE|PDS Biotechnology Corporation (PDSB) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Sonnet BioTherapeutics Holdings Inc. (SONN)|Operatsion marja MAIA Biotechnology Inc (MAIA)|Operatsion rentabellik Liminatus Pharma LIMN|Operatsion foyda normasi LVTX|NXTC: Sotuvning operatsion marjasi|leaptx.com - Operatsion foyda koeffitsiyenti|INTS: Operatsion marja|Sensei Biotherapeutics Inc - Operatsion foyda normasi|Sotuvning operatsion marjasi TOVX|Operatsion foyda bo'yicha sotuv rentabelligi GRTS (Gritstone bio, Inc.)|Sotuvning operatsion marjasi KA (kinetabio.com)|NEXI - Sotuvning operatsion rentabelligi|Turnstone Biologics - Sotuvning operatsion marjasi|Operatsion faoliyat rentabelligi Vaccinex Inc. (VCNX)|harpoontx.com - Operatsion marja